Molecular and functional imaging of cancer: advances in MRI and MRS.
暂无分享,去创建一个
Barjor Gimi | Arvind P Pathak | Ellen Ackerstaff | Kristine Glunde | Dmitri Artemov | Zaver M Bhujwalla | A. Pathak | Z. Bhujwalla | D. Artemov | B. Gimi | E. Ackerstaff | K. Glunde
[1] P. Okunieff,et al. Effects of hydralazine-induced vasodilation on the energy metabolism of murine tumors studied by in vivo 31P-nuclear magnetic resonance spectroscopy. , 1988, Journal of the National Cancer Institute.
[2] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[3] R. Lauffer,et al. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design , 1987 .
[4] P D Ellis,et al. An integrated confocal and magnetic resonance microscope for cellular research. , 2000, Journal of magnetic resonance.
[5] Michal Neeman,et al. In Vivo Prediction of Vascular Susceptibility to Vascular Endothelial Growth Factor Withdrawal Magnetic Resonance Imaging of C6 Rat Glioma in Nude Mice , 1999 .
[6] B R Rosen,et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.
[7] S. Sapareto,et al. In vivo metabolic effects of hyperglycemia in murine radiation-induced fibrosarcoma: a 31P NMR investigation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[8] Jose M. Silva,et al. Increased choline kinase activity in human breast carcinomas: clinical evidence for a potential novel antitumor strategy , 2002, Oncogene.
[9] J. M. Arbeit,et al. Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy. , 1992, Cancer research.
[10] R G Shulman,et al. NMR studies of enzymatic rates in vitro and in vivo by magnetization transfer , 1984, Quarterly Reviews of Biophysics.
[11] S. H. Koenig,et al. Determinants of Proton Relaxation Rates in Tissue , 1984, Magnetic resonance in medicine.
[12] S. Ogawa,et al. Oxygenation‐sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields , 1990, Magnetic resonance in medicine.
[13] D Artemov,et al. Combined vascular and extracellular pH imaging of solid tumors , 2002, NMR in biomedicine.
[14] J R Griffiths,et al. The energy metabolism of RIF-1 tumours following hydralazine. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] J A Frank,et al. Synthesis and relaxometry of high‐generation (G = 5, 7, 9, and 10) PAMAM dendrimer‐DOTA‐gadolinium chelates , 1999, Journal of magnetic resonance imaging : JMRI.
[16] J. Bulte,et al. Short‐ vs. long‐circulating magnetoliposomes as bone marrow‐seeking MR contrast agents , 1999, Journal of magnetic resonance imaging : JMRI.
[17] U Schmiedl,et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. , 1987, Radiology.
[18] P. Lantos,et al. The vasculature of experimental brain tumours Part 1. A sequential light and electron microscope study of angiogenesis , 1981, Journal of the Neurological Sciences.
[19] Andrew G. Webb,et al. Radiofrequency microcoils in magnetic resonance , 1997 .
[20] M. Leach,et al. Magnetic resonance detects changes in phosphocholine associated with Ras activation and inhibition in NIH 3T3 cells , 2001, British Journal of Cancer.
[21] Jeff W. M. Bulte,et al. Synthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites , 2001 .
[22] D L Buckley,et al. MR microscopy of multicomponent diffusion in single neurons , 2001, Magnetic resonance in medicine.
[23] W. Ebert,et al. The Demonstration of Human Tumors on Nude Mice Using Gadolinium‐Labelled Monoclonal Antibodies for Magnetic Resonance Imaging , 1993, Investigative radiology.
[24] J. Denekamp. Limited role of vasculature-mediated injury in tumor response to radiotherapy. , 1993, Journal of the National Cancer Institute.
[25] R. Rosell,et al. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. , 2002, Biochemical and biophysical research communications.
[26] K D Pettigrew,et al. Local Cerebral Blood Flow in the Conscious Rat As Measured with 14C-Antipyrine, 14C-Iodoantipyrine and 3H-Nicotine , 1979, Stroke.
[27] A P Pathak,et al. Utility of simultaneously acquired gradient‐echo and spin‐echo cerebral blood volume and morphology maps in brain tumor patients , 2000, Magnetic resonance in medicine.
[28] B. Quesson,et al. [1‐13C]Glucose Metabolism in the Tumoral and Nontumoral Cerebral Tissue of a Glioma‐Bearing Rat , 1999, Journal of neurochemistry.
[29] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[30] A P Pathak,et al. MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.
[31] Z. Bhujwalla,et al. Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. , 1999, Cancer research.
[32] L. Axel. Cerebral blood flow determination by rapid-sequence computed tomography: theoretical analysis. , 1980, Radiology.
[33] Z. Bhujwalla,et al. Exposure of human breast cancer cells to the anti-inflammatory agent indomethacin alters choline phospholipid metabolites and Nm23 expression. , 2002, Neoplasia.
[34] Scott D Rand,et al. The effect of brain tumor angiogenesis on the in vivo relationship between the gradient‐echo relaxation rate change (ΔR2*) and contrast agent (MION) dose , 2003, Journal of magnetic resonance imaging : JMRI.
[35] S M Wright,et al. Arrays of mutually coupled receiver coils: Theory and application , 1991, Magnetic resonance in medicine.
[36] P Okunieff,et al. Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. , 1989, Radiation research.
[37] G Brix,et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.
[38] D. Noh,et al. Overexpression of phospholipase D1 in human breast cancer tissues. , 2000, Cancer letters.
[39] D. Shahbazi-Gahrouei,et al. In vivo studies of Gd‐DTPA‐monoclonal antibody and gd‐porphyrins: Potential magnetic resonance imaging contrast agents for melanoma , 2001, Journal of magnetic resonance imaging : JMRI.
[40] J Kurhanewicz,et al. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. , 2000, Neoplasia.
[41] K. Schmainda,et al. Water exchange and inflow affect the accuracy of T1‐GRE blood volume measurements: Implications for the evaluation of tumor angiogenesis , 2002, Magnetic resonance in medicine.
[42] D Artemov,et al. Two‐compartment model for determination of glycolytic rates of solid tumors by in vivo 13C NMR spectroscopy , 1998, NMR in biomedicine.
[43] V. L. Doyle,et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy , 2003, Magnetic resonance in medicine.
[44] J R Griffiths,et al. Proton NMR Observation of the Antineoplastic Agent Iproplatin In Vivo by Selective Multiple Quantum Coherence Transfer (Sel‐MQC) , 1995, Magnetic resonance in medicine.
[45] D. Shungu,et al. Band‐selective spin echoes for in vivo localized 1H NMR spectroscopy , 1994, Magnetic resonance in medicine.
[46] H. Degani,et al. The application of 13C NMR to the characterization of phospholipid metabolism in cells , 1992, Magnetic resonance in medicine.
[47] Scott E. Fraser,et al. In vivo visualization of gene expression using magnetic resonance imaging , 2000, Nature Biotechnology.
[48] B R Rosen,et al. Improving MR quantification of regional blood volume with intravascular T1 contrast agents: Accuracy, precision, and water exchange , 1996, Magnetic resonance in medicine.
[49] A. Webb,et al. RF microcoil design for practical NMR of mass-limited samples. , 1998, Journal of magnetic resonance.
[50] R. Weissleder,et al. Oligomerization of paramagnetic substrates result in signal amplification and can be used for MR imaging of molecular targets. , 2002 .
[51] Stefan Miltenyi,et al. Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles , 1992, Magnetic resonance in medicine.
[52] Peter Caravan,et al. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. , 2002, Journal of the American Chemical Society.
[53] B. Fenton,et al. 31P nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia. , 1988, Cancer research.
[54] J. Griffiths,et al. The contribution made by cell death and oxygenation to 31P MRS observations of tumour energy metabolism , 1992, NMR in biomedicine.
[55] C. Sotak,et al. A volume‐localized, two‐dimensional NMR method for the determination of lactate using zero‐quantum coherence created in a stimulated echo pulse sequence , 1988, Magnetic resonance in medicine.
[56] A. Sherry,et al. A novel europium(III)-based MRI contrast agent. , 2001, Journal of the American Chemical Society.
[57] R J Maxwell,et al. Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy. , 2001, Cancer research.
[58] T. Ng,et al. Application ofin vivo NMR spectroscopy to cancer , 1984, Magnetic resonance in medicine.
[59] R. Gillies,et al. Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber. , 2000, Neoplasia.
[60] J W Belliveau,et al. Ultrafast imaging of brain tumors , 1993, Topics in magnetic resonance imaging : TMRI.
[61] Stephen J. Blackband,et al. Nuclear magnetic resonance imaging of a single cell , 1986, Nature.
[62] I. Gribbestad,et al. 1H NMR spectroscopic characterization of perchloric acid extracts from breast carcinomas and non‐involved breast tissue , 1994, NMR in biomedicine.
[63] P Mansfield,et al. A microscope slide probe for high resolution imaging at 11.7 tesla , 1994, Magnetic resonance in medicine.
[64] Donald S. Williams,et al. Multi‐Slice MRI of Rat Brain Perfusion During Amphetamine Stimulation Using Arterial Spin Labeling , 1995, Magnetic resonance in medicine.
[65] P. V. van Zijl,et al. Single-scan in vivo lactate editing with complete lipid and water suppression by selective multiple-quantum-coherence transfer (Sel-MQC) with application to tumors. , 1995, Journal of magnetic resonance. Series B.
[66] H. Degani,et al. Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method. , 1996, Anticancer research.
[67] M. Garwood,et al. Imaging blood flow in brain tumors using arterial spin labeling , 2000, Magnetic resonance in medicine.
[68] J. Glickson,et al. In Vivo 13C NMR spectroscopy of glucose metabolism of RIF‐1 tumors , 1991, Magnetic resonance in medicine.
[69] Ellen Ackerstaff,et al. Real‐time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti‐inflammatory agent indomethacin , 2002, Magnetic resonance in medicine.
[70] Ying Lu,et al. Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients , 2002, Journal of magnetic resonance imaging : JMRI.
[71] I. Solomon. Relaxation Processes in a System of Two Spins , 1955 .
[72] A. Matsumura,et al. MRI contrast enhancement by Gd-DTPA-monoclonal antibody in 9L glioma rats. , 1994, Acta neurochirurgica. Supplementum.
[73] E. Rofstad,et al. Radiation sensitivity of human ovarian carcinoma cell lines in vitro: effects of growth factors and hormones, basement membrane, and intercellular contact. , 1988, International journal of radiation oncology, biology, physics.
[74] R E Hurd,et al. Proton editing and imaging of lactate , 1991, NMR in biomedicine.
[75] P. V. van Zijl,et al. In Vivo proton spectroscopy and spectroscopic imaging of {1‐13C}‐g1ucose and its metabolic products , 1993 .
[76] F. Podo. Tumour phospholipid metabolism , 1999, NMR in biomedicine.
[77] A. Webb,et al. Design of solenoidal microcoils for high-resolution 13C NMR spectroscopy. , 1998, Analytical chemistry.
[78] M. Stampfer,et al. Phospholipases A2 in ras-transformed and immortalized human mammary epithelial cells. , 1994, Cancer letters.
[79] R. Brooks,et al. Relaxometry and magnetometry of the MR contrast agent MION‐46L , 1999, Magnetic resonance in medicine.
[80] B. Sitter,et al. Metabolite composition in breast tumors examined by proton nuclear magnetic resonance spectroscopy. , 1999, Anticancer research.
[81] Richard L. Magin,et al. Integrating microfabricated fluidic systems and NMR spectroscopy , 2000, IEEE Transactions on Biomedical Engineering.
[82] E C Wiener,et al. Development of a tumor-targeting MR contrast agent using the high-affinity folate receptor: work in progress. , 2000, Investigative radiology.
[83] P. Roemer,et al. The NMR phased array , 1990, Magnetic resonance in medicine.
[84] R G Blasberg,et al. Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[85] R. Gillies,et al. In Vitro and in Vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells , 1994, Magnetic resonance in medicine.
[86] B. Rosen,et al. Microscopic susceptibility variation and transverse relaxation: Theory and experiment , 1994, Magnetic resonance in medicine.
[87] R. B. Moon,et al. Determination of intracellular pH by 31P magnetic resonance. , 1973, The Journal of biological chemistry.
[88] Z. Bhujwalla,et al. Effects of blood flow modifiers on tumor metabolism observed in vivo by proton magnetic resonance spectroscopic imaging , 1996, Magnetic resonance in medicine.
[89] Eduard E de Lange,et al. MRI of the lungs using hyperpolarized noble gases , 2002, Magnetic resonance in medicine.
[90] B. Silvestrini,et al. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. , 1981, Journal of the National Cancer Institute.
[91] P. V. van Zijl,et al. Measurement of water–amide proton exchange rates in the denatured state of staphylococcal nuclease by a magnetization transfer technique , 1997, Proteins.
[92] B. Rosen,et al. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.
[93] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[94] P C Lauterbur,et al. Design and analysis of microcoils for NMR microscopy. , 1995, Journal of magnetic resonance. Series B.
[95] P. Joseph,et al. Nuclear magnetic resonance and gamma camera tumor imaging using gadolinium-labeled monoclonal antibodies. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[96] J. Gore,et al. Intravascular susceptibility contrast mechanisms in tissues , 1994, Magnetic resonance in medicine.
[97] Akira Hiraga,et al. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core , 2001, Magnetic resonance in medicine.
[98] Y. Mardor,et al. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study. , 2001, Cancer research.
[99] P. Okunieff,et al. Evaluation of tumor energy metabolism and microvascular blood flow after glucose or mannitol administration using 31P nuclear magnetic resonance spectroscopy and laser Doppler flowmetry. , 1989, International journal of radiation oncology, biology, physics.
[100] D Artemov,et al. Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging. , 1998, Cancer research.
[101] J. Nelson,et al. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. , 2001, Cancer research.
[102] K. Brindle,et al. The appearance of neutral lipid signals in the 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets , 1993, Magnetic resonance in medicine.
[103] Meiyappan Solaiyappan,et al. Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[104] W. A. Murphy,et al. Magnetic resonance imaging using gadolinium labeled monoclonal antibody. , 1985, Investigative radiology.
[105] J R Griffiths,et al. An assessment of 31P MRS as a method of measuring pH in rat tumours , 1992, NMR in biomedicine.
[106] Donald S. Williams,et al. Detection of single mammalian cells by high-resolution magnetic resonance imaging. , 1999, Biophysical journal.
[107] J. Kurhanewicz,et al. Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.
[108] Richard L. Magin,et al. NMR spiral surface microcoils: Design, fabrication, and imaging , 2003 .
[109] T Kubota,et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. , 1993, Radiology.
[110] Jinyuan Zhou,et al. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI , 2003, Nature Medicine.
[111] Mark S. Cohen,et al. Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.
[112] A. Haase,et al. Quantification of regional blood volumes by rapid T1 mapping , 1993, Magnetic resonance in medicine.
[113] R Weissleder,et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. , 1993, Radiology.
[114] David A. Cheresh,et al. Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging , 1998, Nature Medicine.
[115] Alexander Petrovsky,et al. Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture. , 2002, Bioconjugate chemistry.
[116] J. R. Griffiths,et al. Modification of the 31P magnetic resonance spectra of a rat tumour using vasodilators and its relationship to hypotension. , 1990, British Journal of Cancer.
[117] R G Steen,et al. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy. , 1988, Cancer research.
[118] A Mogro-Campero,et al. A high-temperature superconducting receiver for nuclear magnetic resonance microscopy. , 1993, Science.
[119] Peter van Gelderen,et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.
[120] J. Koutcher,et al. Biochemical modulation of tumor cell energy: regression of advanced spontaneous murine breast tumors with a 5-fluorouracil-containing drug combination. , 1992, Cancer research.
[121] R Weissleder,et al. Magnetically labeled cells can be detected by MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[122] B. Rosen,et al. MR Contrast Due to Microscopically Heterogeneous Magnetic Susceptibility: Numerical Simulations and Applications to Cerebral Physiology , 1991, Magnetic resonance in medicine.
[123] T. Mareci,et al. In vivo 1H magnetic resonance imaging and spectroscopy of the rat spinal cord using an inductively‐coupled chronically implanted RF coil , 2001, Magnetic resonance in medicine.
[124] K. Minard,et al. Picoliter 1H NMR Spectroscopy , 2002 .
[125] R. Zhou,et al. In vivo detection of gene expression in liver by 31P nuclear magnetic resonance spectroscopy employing creatine kinase as a marker gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[126] Rugar,et al. Signal-to-noise ratios in inductive and mechanical detection of magnetic resonance. , 1993, Physical review letters.
[127] Corrected equations for susceptibility-induced T2-shortening. , 1999, Journal of magnetic resonance.
[128] R S Balaban,et al. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). , 2000, Journal of magnetic resonance.
[129] C. Starmer,et al. Indicator Transit Time Considered as a Gamma Variate , 1964, Circulation research.
[130] Ming Zhao,et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.
[131] Z. Bhujwalla,et al. Glucose metabolism in RIF‐1 tumors after reduction in blood flow: An in Vivo 13C and 31P NMR study , 1994, Magnetic resonance in medicine.
[132] D. Sodickson,et al. A generalized approach to parallel magnetic resonance imaging. , 2001, Medical physics.
[133] M. Garwood,et al. Localized detection of glioma glycolysis using edited 1H MRS , 1993, Magnetic resonance in medicine.
[134] T. Powles,et al. Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment , 1998, NMR in biomedicine.
[135] C. Ng,et al. Gel‐entrapment of perfluorocarbons: A fluorine‐19 NMR spectroscopic method for monitoring oxygen concentration in cell perfusion systems , 1993, Magnetic resonance in medicine.
[136] Richard L. Magin,et al. High-Resolution Microcoil 1H-NMR for Mass-Limited, Nanoliter-Volume Samples , 1995, Science.
[137] W. Danforth,et al. Effect of pH on the kinetics of frog muscle phosphofructokinase. , 1966, The Journal of biological chemistry.
[138] R. Gruetter,et al. In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.
[139] S. Rockwell,et al. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. , 1984, International journal of radiation oncology, biology, physics.
[140] Nicolaas Bloembergen,et al. Proton Relaxation Times in Paramagnetic Solutions , 1957 .
[141] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis , 1996, Magnetic resonance in medicine.
[142] K. Zierler. Theoretical Basis of Indicator‐Dilution Methods For Measuring Flow and Volume , 1962 .
[143] Sheng-Kwei Song,et al. Improved molecular imaging contrast agent for detection of human thrombus , 2003, Magnetic resonance in medicine.
[144] D Matthaei,et al. 1H NMR chemical shift selective (CHESS) imaging. , 1985, Physics in medicine and biology.
[145] B R Rosen,et al. Mr contrast due to intravascular magnetic susceptibility perturbations , 1995, Magnetic resonance in medicine.
[146] H. Degani,et al. Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[147] D Artemov,et al. In Vivo Selective Measurement of {1−13C}‐Glucose Metabolism in Tumors by Heteronuclear Cross Polarization , 1995, Magnetic resonance in medicine.
[148] P. Okunieff,et al. Tumor size dependent changes in a murine fibrosarcoma: use of in vivo 31P NMR for non-invasive evaluation of tumor metabolic status. , 1986, International journal of radiation oncology, biology, physics.
[149] H. Merkle,et al. Relationships Among Lactate Concentration, Blood Flow and Histopathologic Profiles in Rat C6 Glioma , 1996, NMR in biomedicine.
[150] M. Garwood,et al. Spectral editing with adiabatic pulses. , 1995, Journal of magnetic resonance. Series B.
[151] Alan P Koretsky,et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. , 2003, Blood.
[152] Peter C M van Zijl,et al. Sensitive CEST agents based on nucleic acid imino proton exchange: Detection of poly(rU) and of a dendrimer‐poly(rU) model for nucleic acid delivery and pharmacology , 2003, Magnetic resonance in medicine.
[153] Arvind P Pathak,et al. Novel system for determining contrast agent concentration in mouse blood in vivo , 2004, Magnetic resonance in medicine.
[154] I Barba,et al. The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. , 1999, Cancer research.
[155] A. Volk,et al. Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultured as spheroids and as implanted tumors , 1994, NMR in biomedicine.
[156] S. Cerdán,et al. Imidazol-1-ylalkanoic acids as extrinsic 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume. , 1994, Bioorganic & medicinal chemistry.
[157] Natarajan Raghunand,et al. In vivo imaging of extracellular pH using 1H MRSI , 1999, Magnetic resonance in medicine.
[158] R G Shulman,et al. 31P nuclear magnetic resonance evidence for the regulation of intracellular pH by Ehrlich ascites tumor cells , 1982, The Journal of cell biology.
[159] I. Silver,et al. ATP and Brain Function , 1989, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[160] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[161] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[162] S. Williams,et al. Immortalization and transformation are associated with specific alterations in choline metabolism. , 1996, Cancer research.
[163] Z. H. Cho,et al. Recent progress in NMR microscopy towards cellular imaging , 1990, Philosophical Transactions of the Royal Society of London. Series A: Physical and Engineering Sciences.
[164] L. Ciobanu,et al. Design and testing of high sensitivity microreceiver coil apparatus for nuclear magnetic resonance and imaging , 2001 .
[165] Phosphatidylethanolamine synthesis in the normal and lymphomatous mouse liver; a 13C NMR study. , 1996, Anticancer research.
[166] Arnd Schaff,et al. Mechanically Detected Nuclear Magnetic Resonance at Room Temperature and Normal Pressure , 1997 .
[167] M. Ogan,et al. Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. , 1987, Investigative radiology.
[168] P.-A. Besse,et al. High-Q factor RF planar microcoils for micro-scale NMR spectroscopy , 2002 .
[169] W. Negendank,et al. Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.
[170] J R Griffiths,et al. 31P-NMR investigation of solid tumours in the living rat , 1981, Bioscience reports.
[171] R. Kallman. The phenomenon of reoxygenation and its implications for fractionated radiotherapy. , 1972, Radiology.
[172] F Podo,et al. In vivo 31P MRS of experimental tumours , 1993, NMR in biomedicine.
[173] R S Balaban,et al. Detection of proton chemical exchange between metabolites and water in biological tissues. , 1998, Journal of magnetic resonance.
[174] C. Cheong,et al. One micrometer resolution NMR microscopy. , 2001, Journal of magnetic resonance.
[175] Dmitri Artemov,et al. Magnetic resonance molecular imaging of the HER-2/neu receptor. , 2003, Cancer research.
[176] M O Leach,et al. Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells , 2002, British Journal of Cancer.
[177] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[178] E. Haacke,et al. Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime , 1994, Magnetic resonance in medicine.
[179] B. Rosen,et al. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: Which mean transit time? , 1993, Magnetic resonance in medicine.
[180] Dmitri Artemov,et al. MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.
[181] Z. Bhujwalla,et al. Energy metabolism, pH changes, and lactate production in RIF-1 tumors following intratumoral injection of glucose. , 1992, International journal of radiation oncology, biology, physics.
[182] J. Bulte,et al. Sensitive NMR detection of cationic-polymer-based gene delivery systems using saturation transfer via proton exchange. , 2001, Journal of the American Chemical Society.
[183] Stasia A. Anderson,et al. Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .
[184] Anna Moore,et al. In vivo magnetic resonance imaging of transgene expression , 2000, Nature Medicine.
[185] W. Thilly,et al. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study. , 1995, Cancer research.
[186] A. Fischman,et al. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. , 1991, Radiology.
[187] N. van Bruggen,et al. Assessing tumor angiogenesis using macromolecular MR imaging contrast media , 1997, Journal of magnetic resonance imaging : JMRI.